What is NDC 71335-1132?

71335-1132 is the product NDC for Gabapentin, Gabapentin 600 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.

Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Gabapentin?

561 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Gabapentin NDC 71335-1132 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)71335-1132Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71335-1132Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71335-1132-0	7133511320071335113200	28 TABLET, FILM COATED in 1 BOTTLE (71335-1132-0)Marketed from Apr 2, 2024
71335-1132-1	7133511320171335113201	30 TABLET, FILM COATED in 1 BOTTLE (71335-1132-1)Marketed from Sep 18, 2019
71335-1132-2	7133511320271335113202	60 TABLET, FILM COATED in 1 BOTTLE (71335-1132-2)Marketed from Mar 22, 2019
71335-1132-3	7133511320371335113203	180 TABLET, FILM COATED in 1 BOTTLE (71335-1132-3)Marketed from Mar 24, 2020
71335-1132-4	7133511320471335113204	90 TABLET, FILM COATED in 1 BOTTLE (71335-1132-4)Marketed from Mar 21, 2019
71335-1132-5	7133511320571335113205	100 TABLET, FILM COATED in 1 BOTTLE (71335-1132-5)Marketed from Apr 2, 2024
71335-1132-6	7133511320671335113206	120 TABLET, FILM COATED in 1 BOTTLE (71335-1132-6)Marketed from Apr 5, 2019
71335-1132-7	7133511320771335113207	500 TABLET, FILM COATED in 1 BOTTLE (71335-1132-7)Marketed from Apr 2, 2024
71335-1132-8	7133511320871335113208	84 TABLET, FILM COATED in 1 BOTTLE (71335-1132-8)Marketed from Apr 2, 2024
71335-1132-9	7133511320971335113209	112 TABLET, FILM COATED in 1 BOTTLE (71335-1132-9)Marketed from Apr 2, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Gabapentin
Generic name (nonproprietary): gabapentin
Active ingredients: Gabapentin — 600 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Bryant Ranch PrepackNDC labeler code 71335
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 203244
Marketing start: Jan 11, 2014
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Central Nervous System Disorganized Electrical Activity (Physiologic effect)
Identifiers: Product ID 71335-1132_b600479a-315e-47e3-9c50-bfaab1d5c12cSPL ID b600479a-315e-47e3-9c50-bfaab1d5c12cSPL set ID c9944562-563a-423d-972c-f0313375d234RxCUI 310433UNII 6CW7F3G59X

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471335113200 followed by a unit qualifier and the quantity

Package 71335-1132-00. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 2, 2024.

Indications (excerpt from the label)

Gabapentin tablets are indicated for: Management of postherpetic neuralgia in adults Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy Gabapentin tablets are indicated for: Postherpetic neuralgia in adults ( 1 ) Adjunctive therapy in the treatment of partial onset seizures, with and without secondary generalization, in adults and pediatric patients 3 years and older with epilepsy ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 71335-1132

What is NDC 71335-1132?: 71335-1132 is the product NDC for Gabapentin, Gabapentin 600 mg/1 tablet, film coated, listed with the FDA by Bryant Ranch Prepack. It has 10 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Gabapentin.
What is the active ingredient?: Gabapentin.
Who is the labeler?: Bryant Ranch Prepack, NDC labeler code 71335. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Gabapentin?: 561 other product NDCs are listed under this name. See all Gabapentin NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Gabapentin NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Gabapentin	Gabapentin 800 mg/1	TabletOral	St. Mary's Medical Park Pharmacy	60760-943	60760-0943-3060760-0943-90
gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4763	70518-4763-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0581	55154-0581-00
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	Advanced Rx of Tennessee, LLC	80425-0595	80425-0595-0180425-0595-0280425-0595-03+1 more
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4746	70518-4746-0070518-4746-0170518-4746-02+1 more
Gabapentin	Gabapentin 100 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4742	70518-4742-0070518-4742-02
Gabapentin	Gabapentin 400 mg/1	CapsuleOral	REMEDYREPACK INC.	70518-4740	70518-4740-00
Gabapentin	Gabapentin 300 mg/1	CapsuleOral	Cardinal Health 107, LLC	55154-0580	55154-0580-00
Gabapentin	Gabapentin 600 mg/1	Tablet, CoatedOral	Coupler LLC	67046-1233	67046-1233-03
Gabapentin	Gabapentin 200 mg/1	CapsuleOral	Trifluent Pharma, LLC	73352-231	73352-0231-01

All 562 Gabapentin NDCs

Other NDCs under ANDA 203244

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 203244
Product	Strength	Form · route	Labeler	Product NDC
Gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	St. Mary's Medical Park Pharmacy	60760-066
Gabapentin	Gabapentin 600 mg/1	TabletOral	Strides Pharma Science Limited	64380-727
Gabapentin	Gabapentin 800 mg/1	TabletOral	Strides Pharma Science Limited	64380-728
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-160
Gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Proficient Rx LP	71205-457
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1007
Gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1026
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1041
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	71335-1601
Gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-044
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Aphena Pharma Solutions - Tennessee, LLC	71610-426
Gabapentin	Gabapentin 600 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-2141
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	Bryant Ranch Prepack	72162-2142
Gabapentin	Gabapentin 800 mg/1	Tablet, Film coatedOral	DIRECT RX	72189-158